Nicholson C. David 4
4 · Allergan plc · Filed Aug 7, 2017
Insider Transaction Report
Form 4
Allergan plcAGN
Nicholson C. David
Chief R&D Officer
Transactions
- Tax Payment
Ordinary Shares, par value $0.0001
2017-08-04$242.65/sh−3,898$945,850→ 13,040 total
Footnotes (1)
- [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.